VanEck Associates’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.35M Sell
15,762
-27,242
-63% -$7.51M ﹤0.01% 777
2025
Q1
$11.4M Sell
43,004
-4,799
-10% -$1.27M 0.01% 441
2024
Q4
$11.1M Sell
47,803
-24,705
-34% -$5.74M 0.01% 438
2024
Q3
$16.5M Sell
72,508
-181
-0.2% -$41.1K 0.02% 350
2024
Q2
$14.3M Sell
72,689
-7,258
-9% -$1.43M 0.02% 342
2024
Q1
$17.2M Sell
79,947
-4,398
-5% -$947K 0.03% 302
2023
Q4
$17.8M Sell
84,345
-12,176
-13% -$2.56M 0.03% 274
2023
Q3
$19.3M Sell
96,521
-3,009
-3% -$602K 0.04% 246
2023
Q2
$18.4M Buy
99,530
+6,559
+7% +$1.22M 0.04% 258
2023
Q1
$17.8M Buy
92,971
+16,501
+22% +$3.16M 0.04% 257
2022
Q4
$12.9M Buy
76,470
+32,348
+73% +$5.44M 0.03% 301
2022
Q3
$7.82M Buy
44,122
+1,821
+4% +$323K 0.02% 355
2022
Q2
$8.66M Buy
42,301
+935
+2% +$191K 0.02% 355
2022
Q1
$9.84M Sell
41,366
-3,179
-7% -$756K 0.02% 365
2021
Q4
$10.2M Buy
44,545
+32,169
+260% +$7.35M 0.02% 372
2021
Q3
$2.39M Buy
12,376
+2,593
+27% +$501K 0.01% 630
2021
Q2
$2.08M Sell
9,783
-573
-6% -$122K ﹤0.01% 659
2021
Q1
$2.12M Buy
10,356
+2,792
+37% +$570K 0.01% 599
2020
Q4
$1.38M Sell
7,564
-177
-2% -$32.2K ﹤0.01% 609
2020
Q3
$1.3M Sell
7,741
-9,789
-56% -$1.64M ﹤0.01% 579
2020
Q2
$2.85M Sell
17,530
-5,386
-24% -$875K 0.01% 430
2020
Q1
$3.96M Sell
22,916
-9,682
-30% -$1.67M 0.02% 358
2019
Q4
$6.54M Buy
32,598
+1,385
+4% +$278K 0.03% 325
2019
Q3
$6.6M Buy
31,213
+1,001
+3% +$212K 0.03% 286
2019
Q2
$5.86M Buy
30,212
+2,797
+10% +$543K 0.03% 295
2019
Q1
$4.51M Buy
27,415
+23,224
+554% +$3.82M 0.02% 346
2018
Q4
$788K Buy
4,191
+143
+4% +$26.9K ﹤0.01% 574
2018
Q3
$689K Sell
4,048
-54
-1% -$9.19K ﹤0.01% 638
2018
Q2
$672K Buy
+4,102
New +$672K ﹤0.01% 630